CANbridge Pharmaceuticals
Signal active
Organization
Contact Information
Overview
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan). CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia.
About
Industries
Biotechnology, Health Care, Pharmaceutical
Founded
2012
Employees
101-250
Headquarters locations
Beijing, Beijing, China, Asia
Social
Profile Resume
CANbridge Pharmaceuticals headquartered in Asia, operates in the Biotechnology, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $16.1B in funding across 72 round(s). With a team of 101-250 employees, CANbridge Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - CANbridge Pharmaceuticals, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
2
Lead Investors
0
Total Funding Amount
$224.1M
Details
6
CANbridge Pharmaceuticals has raised a total of $224.1M in funding over 6 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Late Stage Venture | 43.0M | ||
| 2017 | Early Stage Venture | 25.0M | ||
| 2015 | Early Stage Venture | 10.0M | ||
| 2014 | Early Stage Venture | 10.0M |
Investors
CANbridge Pharmaceuticals is funded by 38 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| CANbridge Pharmaceuticals | - | FUNDING ROUND - CANbridge Pharmaceuticals | 10.0M |
| Qiming Venture Partners | - | FUNDING ROUND - Qiming Venture Partners | 10.0M |
| CANbridge Pharmaceuticals | - | FUNDING ROUND - CANbridge Pharmaceuticals | 10.0M |
| TF Capital | - | FUNDING ROUND - TF Capital | 10.0M |
Recent Activity
News
Mar 29, 2024
www.tradingview.com - Current ratio of CANBRIDGE PHARMACEUTICALS INC – HKEX:1228 – TradingView
Funding Round
Dec 01, 2020
CANbridge Pharmaceuticals raised $43000000 on 2020-12-01 in Series E
Funding Round
Feb 18, 2020
CANbridge Pharmaceuticals raised $98000000 on 2020-02-18 in Series D
Funding Round
Aug 01, 2018
CANbridge Pharmaceuticals raised $38100000 on 2018-08-01 in Series C
Funding Round
May 23, 2017
CANbridge Pharmaceuticals raised $25000000 on 2017-05-23 in Series B
Funding Round
Oct 27, 2015
CANbridge Pharmaceuticals raised $10000000 on 2015-10-27 in Series A